The induction of clonal expansion of T cells requires two biologically distinct signals. Signal 1 is generated by interaction of the T cell receptor (TCR) with a MHC-peptide complex, while signal 2 is generated by interaction of the costimulatory molecules on antigen-presenting cells with the receptors for such costimulators on the T cells. Recent studies using models involving CD4 T cells have demonstrated that the consequences of engaging T cell receptor with antigens are determined by delivery of the signal 2. Understanding the delivery of this signal is therefore critical to understanding the induction of the immune response and immune tolerance which has a broad range of significance on vaccination, autoimmunity and transplantation. Two molecules have recently been identified which can act as costimulatory molecules. B7 was originally identified by Linsley and coworkers as a costimulator which binds to CD28/CTLA4. We have recently identified the heat-stable antigen as another costimulator for T cells, although its receptor on T cells has not been identified. In this proposal, we will study the function and molecular basis of the costimulatory pathway mediated by the heat-stable antigen. Three kinds of information are being sought here. a. What is the role of the heat-stable antigen and B7 in CD8 T cell responses? b. What is the molecular basis of the costimulatory pathway mediated by the heat- stable antigen? c. What is the role of the heat stable protein in immune tolerance and autoimmunity? To achieve these goals, we need to study T cell responses to anti-CD3/TCR monoclonal antibodies as well as their specific antigens in a variety of in vivo and in vitro models. We need to use site-directed mutagenesis to generate different variants of the heat-stable antigen to study structural/functional relation of this costimulator molecule. We need to generate monoclonal antibodies which can bind to the putative receptor for the heat-stable antigen on the T cells and use it to clone the receptor on T cells. Finally, we need to use TCR transgenic mice and transgenic mice which express the heat-stable antigen on pancreatic beta cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI032981-01A2
Application #
2067932
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1994-05-01
Project End
1997-04-30
Budget Start
1994-05-01
Budget End
1995-04-30
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
New York University
Department
Pathology
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Bai, Xue-Feng; Li, Ou; Zhou, Qunmin et al. (2004) CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis. J Exp Med 200:447-58
Liu, Xingluo; Gao, Jian Xin; Wen, Jing et al. (2003) B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med 197:1721-30
Gao, Jian-Xin; Liu, Xingluo; Wen, Jing et al. (2003) Two-signal requirement for activation and effector function of natural killer cell response to allogeneic tumor cells. Blood 102:4456-63
Bai, Xue-Feng; Liu, Jinqing; Li, Ou et al. (2003) Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes. J Clin Invest 111:1487-96
Gao, Jian-Xin; Liu, Xingluo; Wen, Jing et al. (2003) Differentiation of monocytic cell clones into CD8 alpha+ dendritic cells (DC) suggests that monocytes can be direct precursors for both CD8 alpha+ and CD8 alpha- DC in the mouse. J Immunol 170:5927-35
Gao, Jian-Xin; Zhang, Huiming; Bai, Xue-Feng et al. (2002) Perinatal blockade of b7-1 and b7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells. J Exp Med 195:959-71
Bai, X F; Gao, J X; Liu, J et al. (2001) On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen. Cancer Res 61:6860-7
Guilloux, Y; Bai, X F; Liu, X et al. (2001) Optimal induction of effector but not memory antitumor cytotoxic T lymphocytes involves direct antigen presentation by the tumor cells. Cancer Res 61:1107-12
Liu, X; Bai, X F; Wen, J et al. (2001) B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo. J Exp Med 194:1339-48
Liu, Y; Zheng, P (2001) Is tumor expression of the major histocompatibility complex antigen required for T cell immune surveillance? Arch Immunol Ther Exp (Warsz) 49 Suppl 2:S61-4

Showing the most recent 10 out of 21 publications